US Stocks
SYRS
Syros Pharmaceuticals, Inc. Common Stock
$0.0004
+0.0000 (+0.00%)
Volume:
1.623K ($0.65)
Market Capitalization:
-
Syros Pharmaceuticals Price Chart
Syros Pharmaceuticals Volume Chart
Syros Pharmaceuticals Market Segments
Regular Trading Hours
+0.0000(+0.00%)
| Open | $0.0004 |
|---|---|
| Close | $0.0004 |
| Low | $0.0004 |
| Low Change | 0.0000 (0.00%) |
| High | $0.0004 |
| High Change | +0.0000 (+0.00%) |
| Range | $0.0000 |
| Volume | 1.623K |
| Dollar Volume | $0.65 |
Premarket
*No Trades in Segment
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
+0.0002(+100.00%)
| Open | $0.0002 |
|---|---|
| Close | $0.0004 |
| Low | $0.0002 |
| Low Change | 0.0000 (0.00%) |
| High | $0.0004 |
| High Change | +0.0002 (+100.00%) |
| Range | $0.0002 |
| Volume | 1.48K |
| Dollar Volume | $0.59 |
Premarket Yesterday
*No Trades in Segment
Syros Pharmaceuticals Moving Averages
| 5 Day Moving Average (SMA5) | $0.0002 |
|---|---|
| 10 Day Moving Average (SMA10) | $0.0003 |
| 20 Day Moving Average (SMA20) | $0.0003 |
| 50 Day Moving Average (SMA50) | $0.0003 |
| 100 Day Moving Average (SMA100) | $0.0003 |
| 200 Day Moving Average (SMA200) | $0.0010 |
Syros Pharmaceuticals Statistics
| Average Volume (30 Days) | 7.17K |
|---|---|
| P/E Ratio (Current) | .00 |
| EPS (Current) | -$3.65 |
| Dividend Yield | — |
| Free Cash Flow | -$100.05M |
| Cash Ratio | 2.05 |
| Current Ratio | 2.25 |
| Quick Ratio | 2.25 |
| Debt to Equity | -3.69 |
| Enterprise Value | -$17.19M |
| EV to EBITDA | 0.16 |
| EV to Sales | -44.54 |
| Price to Book | 0.00 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 0.00 |
| Return on Assets | -1.15% |
| Return on Equity | 8.79% |
Syros Pharmaceuticals Stock Splits
There has been 1 stock split for Syros Pharmaceuticals (SYRS). The reverse stock split occured on September 19, 2022 and reduced the outstanding shares at a ratio of 10:1.
| Date | Type | Ratio |
|---|---|---|
| Sep 19, 2022 | Reverse | 10:1 |
Syros Pharmaceuticals Dividends
There have been no dividends for Syros Pharmaceuticals (SYRS).